Details
Stereochemistry | MIXED |
Molecular Formula | C22H32N2O6.H2O4S |
Molecular Weight | 518.578 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 0 / 2 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
OS(O)(=O)=O.OC(CNCCCCCCNCC(O)C1=CC(O)=C(O)C=C1)C2=CC=C(O)C(O)=C2
InChI
InChIKey=GTDCHGNGVGRHQY-UHFFFAOYSA-N
InChI=1S/C22H32N2O6.H2O4S/c25-17-7-5-15(11-19(17)27)21(29)13-23-9-3-1-2-4-10-24-14-22(30)16-6-8-18(26)20(28)12-16;1-5(2,3)4/h5-8,11-12,21-30H,1-4,9-10,13-14H2;(H2,1,2,3,4)
DescriptionSources: http://www.ncbi.nlm.nih.gov/pubmed/195789Curator's Comment: description was created based on several sources, including, http://home.intekom.com/pharm/intramed/ipradinf.html
Sources: http://www.ncbi.nlm.nih.gov/pubmed/195789
Curator's Comment: description was created based on several sources, including, http://home.intekom.com/pharm/intramed/ipradinf.html
Hexoprenaline is a selective beta2-adrenoreceptor agonist indicated for use in the treatment of bronchospasm associated with obstructive airways diseases, including asthma, bronchitis and emphysema. In many countries the drug is used as tocolytic agent (under the trade name gynipral).
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL210 Sources: http://www.ncbi.nlm.nih.gov/pubmed/195789 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Sources: http://www.ncbi.nlm.nih.gov/pubmed/195789 |
Palliative | Unknown Approved UseUnknown |
||
Primary | Unknown Approved UseUnknown |
|||
Sources: http://www.ncbi.nlm.nih.gov/pubmed/195789 |
Primary | Unknown Approved UseUnknown |
||
Preventing | GYNIPRAL Approved UseGynipral prevents threatened abortion with premature labour. |
PubMed
Title | Date | PubMed |
---|---|---|
Hexoprenaline: a review of its pharmacological properties and therapeutic efficacy with particular reference to asthma. | 1977 Jul |
|
[Tocolysis with hexoprenalin and salbutamol in a clinical comparison]. | 1983 Mar |
|
A comparison of the relative toxicities of beta-sympathomimetic tocolytic agents. | 1985 Oct |
|
Bronchodilators for the prevention and treatment of chronic lung disease in preterm infants. | 2001 |
|
[Comparison of the cost of treatment of premature labor with atosiban or beta-sympathomimetics from the perspective of the health care payer--a pharmacoeconomic model]. | 2004 Mar |
|
Betamimetics for inhibiting preterm labour. | 2004 Oct 18 |
|
Beta 2-agonist treatment enhances uterine oxytocin receptor mRNA expression in pregnant rats. | 2004 Sep |
|
Flow injection potentiometric assay of hexoprenaline in its pure state, pharmaceutical preparations, and biological samples. | 2008 |
|
Treatment of pregnant women with a betamimetic and verapamil increases the micronuclei frequency in umbilical cord blood lymphocytes. | 2008 Aug |
|
Atosiban versus betamimetics in the treatment of preterm labour in Germany: an economic evaluation. | 2009 Jun 19 |
|
Management of foetal asphyxia by intrauterine foetal resuscitation. | 2010 Sep |
|
Dependence of the lymphocyte proliferative response on the endogenous cortisol level and sensitivity to β-adrenergic regulation in vitro in the early period of penetrating eye injury. | 2010 Sep-Oct |
Sample Use Guides
Hexoprenaline can be given by metered aerosol in doses of 200 to 400μg, up to 5 times daily (in asthma), or as an infusion of 0,30 ug and 0,45 ug per minute or as 1-2 tablets q.i.d (0.5 mg per tablet) (maintenance dose in premature labour).
Route of Administration:
Other
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C48149
Created by
admin on Fri Dec 15 15:34:07 GMT 2023 , Edited by admin on Fri Dec 15 15:34:07 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
FF-75
Created by
admin on Fri Dec 15 15:34:07 GMT 2023 , Edited by admin on Fri Dec 15 15:34:07 GMT 2023
|
PRIMARY | |||
|
258331
Created by
admin on Fri Dec 15 15:34:07 GMT 2023 , Edited by admin on Fri Dec 15 15:34:07 GMT 2023
|
PRIMARY | RxNorm | ||
|
250-974-8
Created by
admin on Fri Dec 15 15:34:07 GMT 2023 , Edited by admin on Fri Dec 15 15:34:07 GMT 2023
|
PRIMARY | |||
|
C83756
Created by
admin on Fri Dec 15 15:34:07 GMT 2023 , Edited by admin on Fri Dec 15 15:34:07 GMT 2023
|
PRIMARY | |||
|
CHEMBL1589896
Created by
admin on Fri Dec 15 15:34:07 GMT 2023 , Edited by admin on Fri Dec 15 15:34:07 GMT 2023
|
PRIMARY | |||
|
292266
Created by
admin on Fri Dec 15 15:34:07 GMT 2023 , Edited by admin on Fri Dec 15 15:34:07 GMT 2023
|
PRIMARY | |||
|
m6013
Created by
admin on Fri Dec 15 15:34:07 GMT 2023 , Edited by admin on Fri Dec 15 15:34:07 GMT 2023
|
PRIMARY | Merck Index | ||
|
U851S9102C
Created by
admin on Fri Dec 15 15:34:07 GMT 2023 , Edited by admin on Fri Dec 15 15:34:07 GMT 2023
|
PRIMARY | |||
|
32266-10-7
Created by
admin on Fri Dec 15 15:34:07 GMT 2023 , Edited by admin on Fri Dec 15 15:34:07 GMT 2023
|
PRIMARY | |||
|
36094
Created by
admin on Fri Dec 15 15:34:07 GMT 2023 , Edited by admin on Fri Dec 15 15:34:07 GMT 2023
|
PRIMARY | |||
|
100000086703
Created by
admin on Fri Dec 15 15:34:07 GMT 2023 , Edited by admin on Fri Dec 15 15:34:07 GMT 2023
|
PRIMARY | |||
|
SUB02516MIG
Created by
admin on Fri Dec 15 15:34:07 GMT 2023 , Edited by admin on Fri Dec 15 15:34:07 GMT 2023
|
PRIMARY | |||
|
DBSALT001080
Created by
admin on Fri Dec 15 15:34:07 GMT 2023 , Edited by admin on Fri Dec 15 15:34:07 GMT 2023
|
PRIMARY | |||
|
DTXSID6046688
Created by
admin on Fri Dec 15 15:34:07 GMT 2023 , Edited by admin on Fri Dec 15 15:34:07 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD